Pharma Stocks
-
Ingredion announces strategic partnership with Sanstar Limited expanding access to pharma and food ingredient markets in India
WESTCHESTER, Ill., May 28, 2026 (GLOBE NEWSWIRE) — Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions for…
Read More » -
Is SynAct Pharma (STO:SYNACT) In A Good Position To Deliver On Growth Plans?
Just because a business does not make any money, does not mean that the stock will go down. For example,…
Read More » -
How Investors May Respond To Royalty Pharma (RPRX) Strong Q1 Royalties And Expanding Biotech Partnerships
Royalty Pharma recently reported strong first-quarter 2026 results, highlighting double-digit growth in portfolio and royalty receipts and continued expansion of…
Read More » -
Which Pharma Stock Is the Better Buy?
Novo Nordisk NVO and Amgen AMGN are both global healthcare heavyweights with the scale, financial strength and research depth needed to…
Read More » -
CSPC PHARMA (01093.HK) Lansoprazole Enteric Capsules Receive Drug Registration Approval in China AASTOCKS Financial News
You expressly agree that the use of this app/website is at your sole risk. AASTOCKS.com Limited, HKEx Information Services Limited,…
Read More » -
We Think That There Are Issues Underlying Kwality Pharmaceuticals’ (NSE:KPL) Earnings
Unsurprisingly, Kwality Pharmaceuticals Limited’s (NSE:KPL) stock price was strong on the back of its healthy earnings report. However, our analysis…
Read More » -
A Look At Pharma Mar (BME:PHM) Valuation As Dividend Proposal Puts Shareholder Returns In Focus
Pharma Mar (BME:PHM) has proposed a dividend of €1.00 per share. This corporate action directly affects potential cash returns for…
Read More » -
Assessing Supernus Pharmaceuticals (SUPN) Valuation After Recent Share Price Weakness And Pipeline Progress
Recent performance context for Supernus Pharmaceuticals Without a single headline event driving attention today, Supernus Pharmaceuticals (SUPN) is on some…
Read More » -
Royalty Pharma (RPRX) Valuation Check After Strong Share Price Momentum And Royalty Growth Potential
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors…
Read More » -
MRK Stock Gains After CHMP Backs Keytruda Combo for Bladder Cancer
Shares of Merck MRK rose nearly 6% on Friday after the company announced that the EMA’s Committee for Medicinal Products…
Read More »